Giant Biogene Holding Co., Ltd. (2367.HK)
HKD 80.5
(0.63%)
HKD 80.5
(0.63%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 602.02 Million CNY | 99.88% |
| 2022 | 301.19 Million CNY | -95.61% |
| 2021 | 6.86 Billion CNY | 212.86% |
| 2020 | 2.19 Billion CNY | 239.76% |
| 2019 | 645.48 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q2 | 360.53 Million CNY | 0.0% |
| 2023 Q3 | 602.02 Million CNY | 66.98% |
| 2023 Q1 | 360.53 Million CNY | 19.7% |
| 2023 FY | 602.02 Million CNY | 99.88% |
| 2023 Q4 | 602.02 Million CNY | 0.0% |
| 2022 Q3 | 301.19 Million CNY | 68.84% |
| 2022 FY | 301.19 Million CNY | -95.61% |
| 2022 Q4 | 301.19 Million CNY | 0.0% |
| 2022 Q2 | 178.39 Million CNY | 0.0% |
| 2022 Q1 | - CNY | 0.0% |
| 2021 FY | 6.86 Billion CNY | 212.86% |
| 2020 FY | 2.19 Billion CNY | 239.76% |
| 2019 FY | 645.48 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | -95.426% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 43.397% |
| China Overseas Nuoxin International Holdings Limited | 109.1 Million HKD | -451.808% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | -239.919% |
| Huasheng International Holding Limited | 675.58 Million HKD | 10.888% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -874.077% |
| Evergreen Products Group Limited | 786.46 Million HKD | 23.451% |
| EC Healthcare | 2.97 Billion HKD | 79.732% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 22.018% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 62.788% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | -249.464% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -1304.999% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | -231.974% |